Management of Motor Complications Associated with Advanced Parkinson’s disease

View Activity

PROGRAM CHAIR

Michele Tagliati, MD FAAN
Caron and Steven D. Broidy Chair in Movement Disorders
Professor and Vice Chairman,
Director of Movement Disorders
Department of Neurology
Cedars-Sinai Medical Center
Los Angeles, CA

FACULTY

Samuel Frank, MD
Boston University Neurology
Beth Israel Deaconess Medical Center
Boston, MA

PROGRAM OVERVIEW

This online activity will cover the description of motor complications associated with advanced stages of Parkinson’s disease and their individualized management with both pharmacologic and non-pharmacologic interventions as part of a comprehensive care plan.

TARGET AUDIENCE

This activity is intended for US-based neurologists and primary care providers involved in the management of patients with PD, such as internists, family physicians, physician assistants, nurses, nurse practitioners, social workers, physical therapists, occupational therapists, and speech and language pathologists.

LEARNING OBJECTIVES

Upon completion of the program, attendees should be able to:

  • Review the symptom constellation that may not be resolved by traditional levodopa, including postural instability and falls, speech and swallowing difficulties, and non-motor symptoms.
  • Describe clinical trial evidence supporting the use of interventional therapeutic approaches in the management of PD based on different patient factors
  • List the steps required to restore dopaminergic tone in patients with PD
  • Discuss strategies for comprehensive care and disease management planning, particularly for patients with comorbid conditions

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this enduring activity for a maximum of 1.00 AMA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

Nursing Credit Information
Purpose:
This program would be beneficial for nurses involved in the treatment and management of patients with Parkinson’s disease.
CNE Credits:
1.0 ANCC Contact Hour(s)

CNE Accreditation Statement:
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 1.0 contact hour of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME)
Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF FINANCIAL RELATIONSHIPS

Dr. Tagliati receives a consulting fee from Boston Scientific, Medtronic, and St. Jude/Abbott and a speaker’s honorarium from Medtronic.

Dr. Frank has received grant support from Roche.

CME Content Review
The content of this activity was independently peer reviewed.

The reviewer of this activity has nothing to disclose.

CNE Content Review
The content of this activity was peer reviewed by a nurse.

The reviewer has nothing to disclose.

The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
Lisa Crenshaw, Senior Program Manager for Med Learning Group, has nothing to disclose.
Flavia Piazza, PhD, VP Scientific and Medical Services for Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME/CNE credit for this enduring activity. To receive CME/CNE credit participants must:
1. Read the CME/CNE information and faculty disclosures.
2. Participate in the enduring activity.
3. Submit the evaluation form to Med Learning Group.

You will receive your certification via email within 30 days.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact: Med Learning Group at info@medlearninggroup.com.

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: http://www.medlearninggroup.com/privacy-policy/

RELEASE DATE: July 27, 2018

EXPIRATION DATE: July 27, 2019

View Activity

Participation Statement
This educational activity provides training necessary for licensed attendees to maintain state licensing requirements. The tuition for this educational activity is subsidized in part by unrestricted educational grants, including for those attendees who have successfully completed the state licensing requirements for their respective fields. This subsidy is reflected in the registration fees for this activity.

Copyright © 2018 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.